StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 15 Dec 2022 09:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday New Data Presented at the 2022 San Antonio Breast Cancer Symposium Shows Early Detection using L-Dex and Intervention Improves Lymphedema Progression-Free Survival http://www.streetinsider.com/Press+Releases/New+Data+Presented+at+the+2022+San+Antonio+Breast+Cancer+Symposium+Shows+Early+Detection+using+L-Dex+and+Intervention+Improves+Lymphedema+Progression-Free+Survival/20973597.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/New+Data+Presented+at+the+2022+San+Antonio+Breast+Cancer+Symposium+Shows+Early+Detection+using+L-Dex+and+Intervention+Improves+Lymphedema+Progression-Free+Survival/20973597.html for the full story. http://www.streetinsider.com/Press+Releases/New+Data+Presented+at+the+2022+San+Antonio+Breast+Cancer+Symposium+Shows+Early+Detection+using+L-Dex+and+Intervention+Improves+Lymphedema+Progression-Free+Survival/20973597.html Thu, 15 Dec 2022 09:00:00 -0500 IPD O.06027819 New Data Presented at the 2022 San Antonio Breast Cancer Symposium Shows Early Detection using L-Dex and Intervention Improves Lymphedema Progression-Free Survival http://www.streetinsider.com/Press+Releases/New+Data+Presented+at+the+2022+San+Antonio+Breast+Cancer+Symposium+Shows+Early+Detection+using+L-Dex+and+Intervention+Improves+Lymphedema+Progression-Free+Survival/20973597.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/New+Data+Presented+at+the+2022+San+Antonio+Breast+Cancer+Symposium+Shows+Early+Detection+using+L-Dex+and+Intervention+Improves+Lymphedema+Progression-Free+Survival/20973597.html for the full story. http://www.streetinsider.com/Press+Releases/New+Data+Presented+at+the+2022+San+Antonio+Breast+Cancer+Symposium+Shows+Early+Detection+using+L-Dex+and+Intervention+Improves+Lymphedema+Progression-Free+Survival/20973597.html Thu, 15 Dec 2022 09:00:00 -0500 IPD O.06027819 New Data Presented at the 2022 San Antonio Breast Cancer Symposium Shows Early Detection using L-Dex and Intervention Improves Lymphedema Progression-Free Survival http://www.streetinsider.com/PRNewswire/New+Data+Presented+at+the+2022+San+Antonio+Breast+Cancer+Symposium+Shows+Early+Detection+using+L-Dex+and+Intervention+Improves+Lymphedema+Progression-Free+Survival/20973597.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/New+Data+Presented+at+the+2022+San+Antonio+Breast+Cancer+Symposium+Shows+Early+Detection+using+L-Dex+and+Intervention+Improves+Lymphedema+Progression-Free+Survival/20973597.html for the full story. http://www.streetinsider.com/PRNewswire/New+Data+Presented+at+the+2022+San+Antonio+Breast+Cancer+Symposium+Shows+Early+Detection+using+L-Dex+and+Intervention+Improves+Lymphedema+Progression-Free+Survival/20973597.html Thu, 15 Dec 2022 09:00:00 -0500 IPD O.06027819 New Data Presented at the 2022 San Antonio Breast Cancer Symposium Shows Early Detection using L-Dex and Intervention Improves Lymphedema Progression-Free Survival http://www.streetinsider.com/PRNewswire/New+Data+Presented+at+the+2022+San+Antonio+Breast+Cancer+Symposium+Shows+Early+Detection+using+L-Dex+and+Intervention+Improves+Lymphedema+Progression-Free+Survival/20973597.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/New+Data+Presented+at+the+2022+San+Antonio+Breast+Cancer+Symposium+Shows+Early+Detection+using+L-Dex+and+Intervention+Improves+Lymphedema+Progression-Free+Survival/20973597.html for the full story. http://www.streetinsider.com/PRNewswire/New+Data+Presented+at+the+2022+San+Antonio+Breast+Cancer+Symposium+Shows+Early+Detection+using+L-Dex+and+Intervention+Improves+Lymphedema+Progression-Free+Survival/20973597.html Thu, 15 Dec 2022 09:00:00 -0500 IPD O.06027819 ImpediMed Extends Contract for AstraZeneca for Use of the SOZO Digital Health Platform in Clinical Trial of Patients with Chronic Kidney Disease http://www.streetinsider.com/Press+Releases/ImpediMed+Extends+Contract+for+AstraZeneca+for+Use+of+the+SOZO+Digital+Health+Platform+in+Clinical+Trial+of+Patients+with+Chronic+Kidney+Disease/20861455.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ImpediMed+Extends+Contract+for+AstraZeneca+for+Use+of+the+SOZO+Digital+Health+Platform+in+Clinical+Trial+of+Patients+with+Chronic+Kidney+Disease/20861455.html for the full story. http://www.streetinsider.com/Press+Releases/ImpediMed+Extends+Contract+for+AstraZeneca+for+Use+of+the+SOZO+Digital+Health+Platform+in+Clinical+Trial+of+Patients+with+Chronic+Kidney+Disease/20861455.html Wed, 16 Nov 2022 09:00:00 -0500 IPD O.06027819 ImpediMed Extends Contract for AstraZeneca for Use of the SOZO Digital Health Platform in Clinical Trial of Patients with Chronic Kidney Disease http://www.streetinsider.com/Press+Releases/ImpediMed+Extends+Contract+for+AstraZeneca+for+Use+of+the+SOZO+Digital+Health+Platform+in+Clinical+Trial+of+Patients+with+Chronic+Kidney+Disease/20861455.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ImpediMed+Extends+Contract+for+AstraZeneca+for+Use+of+the+SOZO+Digital+Health+Platform+in+Clinical+Trial+of+Patients+with+Chronic+Kidney+Disease/20861455.html for the full story. http://www.streetinsider.com/Press+Releases/ImpediMed+Extends+Contract+for+AstraZeneca+for+Use+of+the+SOZO+Digital+Health+Platform+in+Clinical+Trial+of+Patients+with+Chronic+Kidney+Disease/20861455.html Wed, 16 Nov 2022 09:00:00 -0500 IPD O.06027819 ImpediMed Extends Contract for AstraZeneca for Use of the SOZO Digital Health Platform in Clinical Trial of Patients with Chronic Kidney Disease http://www.streetinsider.com/PRNewswire/ImpediMed+Extends+Contract+for+AstraZeneca+for+Use+of+the+SOZO+Digital+Health+Platform+in+Clinical+Trial+of+Patients+with+Chronic+Kidney+Disease/20861455.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/ImpediMed+Extends+Contract+for+AstraZeneca+for+Use+of+the+SOZO+Digital+Health+Platform+in+Clinical+Trial+of+Patients+with+Chronic+Kidney+Disease/20861455.html for the full story. http://www.streetinsider.com/PRNewswire/ImpediMed+Extends+Contract+for+AstraZeneca+for+Use+of+the+SOZO+Digital+Health+Platform+in+Clinical+Trial+of+Patients+with+Chronic+Kidney+Disease/20861455.html Wed, 16 Nov 2022 09:00:00 -0500 IPD O.06027819 ImpediMed Extends Contract for AstraZeneca for Use of the SOZO Digital Health Platform in Clinical Trial of Patients with Chronic Kidney Disease http://www.streetinsider.com/PRNewswire/ImpediMed+Extends+Contract+for+AstraZeneca+for+Use+of+the+SOZO+Digital+Health+Platform+in+Clinical+Trial+of+Patients+with+Chronic+Kidney+Disease/20861455.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/ImpediMed+Extends+Contract+for+AstraZeneca+for+Use+of+the+SOZO+Digital+Health+Platform+in+Clinical+Trial+of+Patients+with+Chronic+Kidney+Disease/20861455.html for the full story. http://www.streetinsider.com/PRNewswire/ImpediMed+Extends+Contract+for+AstraZeneca+for+Use+of+the+SOZO+Digital+Health+Platform+in+Clinical+Trial+of+Patients+with+Chronic+Kidney+Disease/20861455.html Wed, 16 Nov 2022 09:00:00 -0500 IPD O.06027819 ImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platform http://www.streetinsider.com/Press+Releases/ImpediMed+Reaches+Milestone+of+500%2C000+Patient+Tests+Performed+with+the+SOZO+Digital+Health+Platform/20783693.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ImpediMed+Reaches+Milestone+of+500%2C000+Patient+Tests+Performed+with+the+SOZO+Digital+Health+Platform/20783693.html for the full story. http://www.streetinsider.com/Press+Releases/ImpediMed+Reaches+Milestone+of+500%2C000+Patient+Tests+Performed+with+the+SOZO+Digital+Health+Platform/20783693.html Wed, 02 Nov 2022 09:00:00 -0500 IPD O.06027819 ImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platform http://www.streetinsider.com/Press+Releases/ImpediMed+Reaches+Milestone+of+500%2C000+Patient+Tests+Performed+with+the+SOZO+Digital+Health+Platform/20783693.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ImpediMed+Reaches+Milestone+of+500%2C000+Patient+Tests+Performed+with+the+SOZO+Digital+Health+Platform/20783693.html for the full story. http://www.streetinsider.com/Press+Releases/ImpediMed+Reaches+Milestone+of+500%2C000+Patient+Tests+Performed+with+the+SOZO+Digital+Health+Platform/20783693.html Wed, 02 Nov 2022 09:00:00 -0500 IPD O.06027819 ImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platform http://www.streetinsider.com/PRNewswire/ImpediMed+Reaches+Milestone+of+500%2C000+Patient+Tests+Performed+with+the+SOZO+Digital+Health+Platform/20783693.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/ImpediMed+Reaches+Milestone+of+500%2C000+Patient+Tests+Performed+with+the+SOZO+Digital+Health+Platform/20783693.html for the full story. http://www.streetinsider.com/PRNewswire/ImpediMed+Reaches+Milestone+of+500%2C000+Patient+Tests+Performed+with+the+SOZO+Digital+Health+Platform/20783693.html Wed, 02 Nov 2022 09:00:00 -0500 IPD O.06027819 ImpediMed Reaches Milestone of 500,000 Patient Tests Performed with the SOZO Digital Health Platform http://www.streetinsider.com/PRNewswire/ImpediMed+Reaches+Milestone+of+500%2C000+Patient+Tests+Performed+with+the+SOZO+Digital+Health+Platform/20783693.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/ImpediMed+Reaches+Milestone+of+500%2C000+Patient+Tests+Performed+with+the+SOZO+Digital+Health+Platform/20783693.html for the full story. http://www.streetinsider.com/PRNewswire/ImpediMed+Reaches+Milestone+of+500%2C000+Patient+Tests+Performed+with+the+SOZO+Digital+Health+Platform/20783693.html Wed, 02 Nov 2022 09:00:00 -0500 IPD O.06027819 Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related Lymphedema http://www.streetinsider.com/Press+Releases/Current+Data+Support+Early+Detection+and+Intervention+to+Reduce+Rates+of+Breast+Cancer-Related+Lymphedema/20747552.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Current+Data+Support+Early+Detection+and+Intervention+to+Reduce+Rates+of+Breast+Cancer-Related+Lymphedema/20747552.html for the full story. http://www.streetinsider.com/Press+Releases/Current+Data+Support+Early+Detection+and+Intervention+to+Reduce+Rates+of+Breast+Cancer-Related+Lymphedema/20747552.html Wed, 26 Oct 2022 09:00:00 -0500 IPD O.06027819 Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related Lymphedema http://www.streetinsider.com/Press+Releases/Current+Data+Support+Early+Detection+and+Intervention+to+Reduce+Rates+of+Breast+Cancer-Related+Lymphedema/20747552.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Current+Data+Support+Early+Detection+and+Intervention+to+Reduce+Rates+of+Breast+Cancer-Related+Lymphedema/20747552.html for the full story. http://www.streetinsider.com/Press+Releases/Current+Data+Support+Early+Detection+and+Intervention+to+Reduce+Rates+of+Breast+Cancer-Related+Lymphedema/20747552.html Wed, 26 Oct 2022 09:00:00 -0500 IPD O.06027819 Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related Lymphedema http://www.streetinsider.com/PRNewswire/Current+Data+Support+Early+Detection+and+Intervention+to+Reduce+Rates+of+Breast+Cancer-Related+Lymphedema/20747552.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Current+Data+Support+Early+Detection+and+Intervention+to+Reduce+Rates+of+Breast+Cancer-Related+Lymphedema/20747552.html for the full story. http://www.streetinsider.com/PRNewswire/Current+Data+Support+Early+Detection+and+Intervention+to+Reduce+Rates+of+Breast+Cancer-Related+Lymphedema/20747552.html Wed, 26 Oct 2022 09:00:00 -0500 IPD O.06027819 Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer-Related Lymphedema http://www.streetinsider.com/PRNewswire/Current+Data+Support+Early+Detection+and+Intervention+to+Reduce+Rates+of+Breast+Cancer-Related+Lymphedema/20747552.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Current+Data+Support+Early+Detection+and+Intervention+to+Reduce+Rates+of+Breast+Cancer-Related+Lymphedema/20747552.html for the full story. http://www.streetinsider.com/PRNewswire/Current+Data+Support+Early+Detection+and+Intervention+to+Reduce+Rates+of+Breast+Cancer-Related+Lymphedema/20747552.html Wed, 26 Oct 2022 09:00:00 -0500 IPD O.06027819 New Data Confirms Early Detection and Intervention of Lymphedema Improves Quality of Life for Breast Cancer Patients Who Avoid Chronic Lymphedema http://www.streetinsider.com/Press+Releases/New+Data+Confirms+Early+Detection+and+Intervention+of+Lymphedema+Improves+Quality+of+Life+for+Breast+Cancer+Patients+Who+Avoid+Chronic+Lymphedema/20725583.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/New+Data+Confirms+Early+Detection+and+Intervention+of+Lymphedema+Improves+Quality+of+Life+for+Breast+Cancer+Patients+Who+Avoid+Chronic+Lymphedema/20725583.html for the full story. http://www.streetinsider.com/Press+Releases/New+Data+Confirms+Early+Detection+and+Intervention+of+Lymphedema+Improves+Quality+of+Life+for+Breast+Cancer+Patients+Who+Avoid+Chronic+Lymphedema/20725583.html Thu, 20 Oct 2022 09:00:00 -0500 IPD O.06027819 New Data Confirms Early Detection and Intervention of Lymphedema Improves Quality of Life for Breast Cancer Patients Who Avoid Chronic Lymphedema http://www.streetinsider.com/Press+Releases/New+Data+Confirms+Early+Detection+and+Intervention+of+Lymphedema+Improves+Quality+of+Life+for+Breast+Cancer+Patients+Who+Avoid+Chronic+Lymphedema/20725583.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/New+Data+Confirms+Early+Detection+and+Intervention+of+Lymphedema+Improves+Quality+of+Life+for+Breast+Cancer+Patients+Who+Avoid+Chronic+Lymphedema/20725583.html for the full story. http://www.streetinsider.com/Press+Releases/New+Data+Confirms+Early+Detection+and+Intervention+of+Lymphedema+Improves+Quality+of+Life+for+Breast+Cancer+Patients+Who+Avoid+Chronic+Lymphedema/20725583.html Thu, 20 Oct 2022 09:00:00 -0500 IPD O.06027819 New Data Confirms Early Detection and Intervention of Lymphedema Improves Quality of Life for Breast Cancer Patients Who Avoid Chronic Lymphedema http://www.streetinsider.com/PRNewswire/New+Data+Confirms+Early+Detection+and+Intervention+of+Lymphedema+Improves+Quality+of+Life+for+Breast+Cancer+Patients+Who+Avoid+Chronic+Lymphedema/20725583.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/New+Data+Confirms+Early+Detection+and+Intervention+of+Lymphedema+Improves+Quality+of+Life+for+Breast+Cancer+Patients+Who+Avoid+Chronic+Lymphedema/20725583.html for the full story. http://www.streetinsider.com/PRNewswire/New+Data+Confirms+Early+Detection+and+Intervention+of+Lymphedema+Improves+Quality+of+Life+for+Breast+Cancer+Patients+Who+Avoid+Chronic+Lymphedema/20725583.html Thu, 20 Oct 2022 09:00:00 -0500 IPD O.06027819 New Data Confirms Early Detection and Intervention of Lymphedema Improves Quality of Life for Breast Cancer Patients Who Avoid Chronic Lymphedema http://www.streetinsider.com/PRNewswire/New+Data+Confirms+Early+Detection+and+Intervention+of+Lymphedema+Improves+Quality+of+Life+for+Breast+Cancer+Patients+Who+Avoid+Chronic+Lymphedema/20725583.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/New+Data+Confirms+Early+Detection+and+Intervention+of+Lymphedema+Improves+Quality+of+Life+for+Breast+Cancer+Patients+Who+Avoid+Chronic+Lymphedema/20725583.html for the full story. http://www.streetinsider.com/PRNewswire/New+Data+Confirms+Early+Detection+and+Intervention+of+Lymphedema+Improves+Quality+of+Life+for+Breast+Cancer+Patients+Who+Avoid+Chronic+Lymphedema/20725583.html Thu, 20 Oct 2022 09:00:00 -0500 IPD O.06027819 ImpediMed Expands Use of SOZO in Leading Cancer Centers Focused on Reducing the Impact of Lymphedema after Breast Cancer http://www.streetinsider.com/Press+Releases/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html for the full story. http://www.streetinsider.com/Press+Releases/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html Tue, 11 Oct 2022 09:00:00 -0500 A.07309385 IPD O.06027819 O.20043539 ImpediMed Expands Use of SOZO in Leading Cancer Centers Focused on Reducing the Impact of Lymphedema after Breast Cancer http://www.streetinsider.com/Press+Releases/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html for the full story. http://www.streetinsider.com/Press+Releases/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html Tue, 11 Oct 2022 09:00:00 -0500 A.07309385 IPD O.06027819 O.20043539 ImpediMed Expands Use of SOZO in Leading Cancer Centers Focused on Reducing the Impact of Lymphedema after Breast Cancer http://www.streetinsider.com/Press+Releases/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html for the full story. http://www.streetinsider.com/Press+Releases/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html Tue, 11 Oct 2022 09:00:00 -0500 A.07309385 IPD O.06027819 O.20043539 ImpediMed Expands Use of SOZO in Leading Cancer Centers Focused on Reducing the Impact of Lymphedema after Breast Cancer http://www.streetinsider.com/Press+Releases/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html for the full story. http://www.streetinsider.com/Press+Releases/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html Tue, 11 Oct 2022 09:00:00 -0500 A.07309385 IPD O.06027819 O.20043539 ImpediMed Expands Use of SOZO in Leading Cancer Centers Focused on Reducing the Impact of Lymphedema after Breast Cancer http://www.streetinsider.com/PRNewswire/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html for the full story. http://www.streetinsider.com/PRNewswire/ImpediMed+Expands+Use+of+SOZO+in+Leading+Cancer+Centers+Focused+on+Reducing+the+Impact+of+Lymphedema+after+Breast+Cancer/20686909.html Tue, 11 Oct 2022 09:00:00 -0500 A.07309385 IPD O.06027819 O.20043539